1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Global Markets for Animal Therapeutics and Diagnostics

Global Markets for Animal Therapeutics and Diagnostics

  • February 2017
  • -
  • BCC Research
  • -
  • 256 pages

Use this report to:
- Analyze market segments, namely vaccines, pharmaceuticals, feed additives and diagnostics
- Receive information about product categories, use of products, forecasts and competitive analyses
- Evaluate trends in the industry, market drivers and factors affecting the animal therapeutics and diagnostics market
- Analyze the profiles of major players in the field of animal therapeutics and diagnostics

Highlights
- The global market for animal therapeutics and diagnostics totaled nearly $40.1 billion in 2016 and should total $47.9 billion in 2021, registering a compound annual growth rate (CAGR) of 3.6% for the period 2016-2021.
- Pharmaceutical products as a segment totaled nearly $17.3 billion in 2016 and should total
$21.5 billion by 2021 at a 4.5% CAGR for the period 2016-2021.
- Feed additives as a segment totaled $13.5 billion in 2016 and should total $14.4 billion in 2021, increasing at a CAGR of 1.3% from 2016-2021.

STUDY GOALS AND OBJECTIVES
This BCC Research report, Global Markets for Animal Therapeutics and Diagnostics, provides an overview of products included in this market and detailed market analyses and competitive environments. The study includes information about significant products, players, issues and trends, and other information affecting the animal therapeutics and diagnostics market.

REASONS FOR DOING THE STUDY
The animal health industry is responsible for maintaining the health and productivity of the more than 3 billion livestock and more than 50 billion poultry worldwide and ensuring the wholesomeness and abundance of the food it produces. In addition, the industry must also cater to the health and well-being of companion animals. Despite this, the human healthcare market is 30 times larger than the combined market for all nonhuman species. The reality is that the global animal health market is very complex, operating under stringent and increasingly strict regulations similar to those for human health, yet the market opportunities are considerably smaller. In an increasingly risky environment for new product development, the difference between success and failure in the future usually lies in successfully identifying the next growth segment, developing the right product candidates and being the first to market. Despite all these risks, the industry continues to grow.

In contrast to human blockbuster-oriented pharmaceuticals, animal health is dominated by a large number of products with small revenues. Although there are hundreds of products offered in the animal health market, only a couple dozen products have sales exceeding $100 million per year. However, the industry continues to forge on. The fastest growing therapeutic categories are in the area of companion animals, specifically in the allergy and respiratory and arthritis and pain segments of the market.

A challenging aspect of the animal health market is within the animal food industry as consumers continue to express concern about the conditions under which their daily food is produced. Consumers are becoming more health conscious and demanding healthy and balanced diets. The growing trend of natural and organic food is creating a niche market opportunity for suppliers. By implementing a feeding plan that provides vitamins and supplements, consumers enjoy additional nutritional benefits. Additionally, healthy feeding results in minimized impact on the environment.

INTENDED AUDIENCE
The information within this report is directed at the business and industry professional and is specifically designed to aid in the explanation, direction and future of animal health markets. The report focuses on providing the reader with an understanding of trends in the industry, market segments, market forecasts, leading players, market drivers and inhibitors.

SCOPE OF REPORT
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.

INFORMATION SOURCES
The information for this BCC report was obtained through extensive primary research methods and supportive secondary data-collection methods. Primary methods included interviews with approximately 40 key executives, product managers and clinical specialists involved in the animal health industry. Secondary methods included published literature in the area of animal science and veterinary services, investment reports, company literature and various animal health journals.

All market data pertain to the global market at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year of the report is 2016, with historical data provided for 2014 and 2015, and forecast data provided for 2021. Historical, base year and forecast data are provided for each market segment of the report. Competitor market share estimates are provided for each market segment for the 2016 base year.

Although this study provides information on a variety of products used to treat animals, it does not include a comprehensive list of all products available.

ANALYST’S CREDENTIALS
Melissa Elder is an experienced healthcare market analyst specializing in prescription and over-the-counter pharmaceuticals, medical devices and emerging healthcare technologies. Ms. Elder has more than 20 years of experience in the healthcare industry, specializing in market research for the past 16 years. This experience has given her substantial insight into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into a wide range of healthcare markets.

Table Of Contents

Global Markets for Animal Therapeutics and Diagnostics
TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THE STUDY 2
INTENDED AUDIENCE 2
SCOPE OF REPORT 3
INFORMATION SOURCES 3
RELATED BCC RESEARCH REPORTS 3
ANALYST'S CREDENTIALS 4
BCC RESEARCH WEBSITE 4
DISCLAIMER 4
CHAPTER 2 SUMMARY 6
MARKET OVERVIEW 6
SUMMARY TABLE GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, THROUGH 2021 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, 2014-2021 ($ MILLIONS) 7
LEADING MANUFACTURERS AND SUPPLIERS 7
CHAPTER 3 INDUSTRY OVERVIEW 10
ANIMAL ANATOMY AND PHYSIOLOGY 10
REPRODUCTIVE SYSTEM 11
TABLE 1 GESTATION PERIODS OF SELECT COMMON SPECIES 12
AVIAN ANATOMY 12
TABLE 2 LIFESPAN OF COMMON AVIAN SPECIES OF PETS 15
ANIMAL POPULATIONS IN THE UNITED STATES 15
COMPANION ANIMALS 15
TABLE 3 STATISTICS FOR COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2011, 2014 AND 2016 (THOUSANDS/%) 15
TABLE 4 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2014 AND 2016 (THOUSANDS) 16
FOOD PRODUCTION ANIMALS 16
TABLE 5 REPORTED POPULATION OF FOOD PRODUCTION ANIMALS IN THE UNITED STATES, 2005, 2010, 2014, 2016 AND PROJECTED 2017 (THOUSANDS) 17
Livestock Production - Top States 17
TABLE 6 TOP BROILER PRODUCING STATES, 2015 (THOUSANDS) 18
TABLE 7 TOP RED MEAT PRODUCING STATES, 1990 AND 2015 (%) 18
ANIMAL POPULATIONS BY COUNTRY 19
DOGS 19
TABLE 8 DOG (CANINE) POPULATION BY SELECT COUNTRY, 2015 (THOUSANDS) 19
CATS 19
TABLE 9 CAT (FELINE) POPULATION BY SELECT COUNTRY, 2015 (THOUSANDS) 20
HORSES 20
TABLE 10 HORSE (EQUINE) POPULATION BY COUNTRY, 2016 (THOUSANDS) 20
CATTLE 21
TABLE 11 CATTLE (BOVINE) POPULATION BY COUNTRY, 2016 (THOUSANDS) 21
SWINE 21
TABLE 12 PIG/HOG (SWINE) POPULATION BY COUNTRY, 2016 (THOUSANDS) 21
SHEEP 22
GOATS 22
ZOONOTIC DISEASES 22
TABLE 13 COMMON EXAMPLES OF ZOONOTIC DISEASES 24
CHAPTER 4 ISSUES AFFECTING THE MARKET 26
OVERVIEW 26
LEGAL AND REGULATORY ISSUES 26
REGULATORY AGENCIES INVOLVED IN ANIMAL HEALTH AND WELFARE 26
Food and Drug Administration (FDA) 26
FDA's Center for Veterinary Medicine (CVM) 26
U.S. Department of Agriculture (USDA) 26
European Medicines Agency (EMA) and Committee for Medicinal Products for Veterinary Use (CVMP) 27
Australian Pesticides and Veterinary Medicines Authority (APVMA) 27
The Ministry of Agriculture, Livestock and Supply (MAPA) of Brazil 27
ANTIBIOTIC USE AND RESISTANCE IN PRODUCTION ANIMALS 27
FDA's Antimicrobial Restrictions 27
TABLE 14 AFFECTED PIONEER ANTIMICROBIALS USED IN FOOD-PRODUCING ANIMALS IN THE UNITED STATES 29
Losing Livestock 32
Corporate Response Concerning Responsible Use 33
Therapeutic Use 33
Resistance 34
TABLE 15 ANTIMICROBIAL DRUG USE AND SALES IN FOOD-PRODUCING ANIMALS, 2010, 2011 AND 2014 (KG*) 35
Human Side Effects 36
Microbial Ecology 36
Agriculture and Food Research Initiative 36
Levels of Contaminated Meats in the U.S. 36
Movement for Lower Amounts of Antibiotics in Livestock Production 37
MINIMALLY AND HIGHLY REGULATED PRODUCTS 37
ANIMAL DRUG USER FEE ACT OF 2003 38
ANIMAL DRUG USER FEE AMENDMENTS OF 2008 (ADUFA II) 38
ANIMAL DRUG USER FEE AMENDMENTS OF 2013 (ADUFA III) 38
BIOTECHNOLOGY IN ANIMAL HEALTH 39
ANIMAL CLONING 39
PROBIOTICS 40
ANIMAL OBESITY 40
CAUSES 41
WEIGHT REDUCTION 41
TRENDS IN COMPANION PET OWNERSHIP 42
ANIMAL HEALTH INSURANCE 43
TABLE 16 APPA NATIONAL PET OWNERS SURVEY, 2013 AND 2014 BASIC ANNUAL EXPENSES FOR DOGS AND CATS (U.S. SPENDING, $) 44
TABLE 17 PET INSURANCE PLAN COMPARISONS, UNITED STATES 44
ADVANCED MEDICAL PROCEDURES 45
LIFE CYCLE APPROACH 46
DEMAND IN THE VETERINARY SERVICE INDUSTRY 47
TABLE 18 NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS. 2015 48
FIGURE 1 NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS 2015 49
TABLE 19 ESTIMATED NUMBER OF U.S. PRIVATE VETERINARIAN PRACTICES, BY TYPE OF PRACTICE, 2013 AND 2015 49
TABLE 20 GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS) 50
FIGURE 2 ESTIMATED NUMBER OF VETERINARIANS IN THE UNITED STATES BY GENDER* AND YEAR, 2009-2015 50
CHAPTER 5 ANIMAL VACCINES 53
OVERVIEW 53
GLOBAL MARKET ANALYSIS AND CONSIDERATIONS 53
TABLE 21 GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS) 53
FIGURE 3 GLOBAL MARKET SHARES OF ANIMAL VACCINES BY ANIMAL GROUP, 2016 (%) 53
GLOBAL MARKET BY GEOGRAPHICAL REGION 54
TABLE 22 GLOBAL MARKET FOR ANIMAL VACCINES BY REGION, THROUGH 2021 ($ MILLIONS) 55
FIGURE 4 GLOBAL MARKET SHARES OF ANIMAL VACCINES BY REGION, 2016 (%) 55
COMPETITIVE SUMMARY 56
TABLE 23 GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 ($ MILLIONS/%) 56
FIGURE 5 GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%) 56
PRODUCT INTRODUCTION 57
ACTIVE IMMUNITY 57
PASSIVE IMMUNITY 58
OTHER TYPES 58
COMPANION ANIMALS 58
VIRUSES 58
Adenovirus 59
Avian Influenza 59
Coronavirus 60
Distemper 60
Eastern Equine Encephalitis 60
Equine Viral Arteritis 61
Feline Calicivirus and Feline Herpes Virus 61
Feline Immunosuppressive Virus 61
Feline Infectious Peritonitis Virus 62
Feline Leukemia Virus 62
Hendra Virus 62
TABLE 24 HENDRA VIRUS EQUINE INCIDENTS (NUMBER OF REPORTED CASES) 63
Infectious Hepatitis 63
Internal Papillomatosis of Parrots 63
Newcastle Disease 64
Pacheco's Disease 64
Parainfluenza Virus 65
Paramyxoviruses 65
Parvovirus 66
Polyomavirus 66
Poxviruses 66
Psittacine Beak and Feather Disease 67
Rabies 67
Reovirus 67
West Nile Virus 68
VACCINE PROVIDERS 68
Boehringer Ingelheim/Vetmedica 68
TABLE 25 BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES BY TARGET SPECIES 69
FIGURE 6 BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 69
Elanco 70
TABLE 26 ELANCO'S COMPANION ANIMAL VACCINES BY TARGET SPECIES 70
Merck Animal Health 70
TABLE 27 MERCK'S COMPANION ANIMAL VACCINES BY TARGET SPECIES 71
FIGURE 7 MERCK'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 71
Merial 72
TABLE 28 MERIAL'S COMPANION ANIMAL VACCINES BY TARGET SPECIES 73
FIGURE 8 MERIAL'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 73
Zoetis 74
TABLE 29 ZOETIS' COMPANION ANIMAL VACCINES BY TARGET SPECIES 75
FIGURE 9 ZOETIS' COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 75
COMPANION ANIMAL VACCINES MARKET ANALYSIS 76
FIGURE 10 GLOBAL MARKET FOR COMPANION ANIMAL VACCINES BY ANIMAL SPECIES, 2014-2021 ($ MILLIONS) 76
FIGURE 11 GLOBAL REVENUES FOR COMPANION ANIMAL VACCINES BY TYPE, 2014-2021 ($ MILLIONS) 77
PRODUCTION ANIMALS 78
VIRUSES AND PRIONS 78
Avian Pneumovirus 78
Bovine Spongiform Encephalopathy 79
Bovine Viral Diarrhea 79
Classical Swine Fever 80
Foot and Mouth Disease 81
Furunculosis 81
Infectious Pancreatic Necrosis 81
Marek's Disease 81
Pathogenic Avian Influenza 82
Q Fever 82
Vesicular Stomatitis 83
VACCINE PROVIDERS 83
Bayer 83
TABLE 30 BAYER'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 83
Boehringer Ingelheim 83
TABLE 31 BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 84
FIGURE 12 BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 84
Elanco 85
TABLE 32 ELANCO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 85
FIGURE 13 ELANCO'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 86
Merck and Co. 86
TABLE 33 MERCK and CO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 87
FIGURE 14 MERCK'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 88
Merial 89
TABLE 34 MERIAL'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 89
FIGURE 15 MERIAL'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 89
Zoetis 90
TABLE 35 ZOETIS' PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 91
FIGURE 16 ZOETIS' PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 92
PRODUCTION ANIMAL VACCINE MARKET ANALYSIS 93
FIGURE 17 GLOBAL MARKET FOR PRODUCTION ANIMAL VACCINES BY ANIMAL SPECIES, 2014-2021 93
FIGURE 18 GLOBAL MARKET FOR PRODUCTION ANIMAL VACCINES BY TYPE, 2014-2021 ($ MILLIONS) 94
CHAPTER 6 ANIMAL PHARMACEUTICAL PRODUCTS 97
OVERVIEW 97
GLOBAL MARKET ANALYSIS AND CONSIDERATIONS 97
TABLE 36 GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2021 ($ MILLIONS) 98
FIGURE 19 GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, 2016-2021 ($ MILLIONS) 98
COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS 98
TABLE 37 GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS) 99
FIGURE 20 GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCTS BY ANIMAL GROUP, 2016 (%) 99
MARKETS BY GEOGRAPHICAL REGION 100
TABLE 38 GLOBAL MARKET FOR ANIMAL PHARMACEUTICALS BY REGION, THROUGH 2021 ($ MILLIONS) 100
FIGURE 21 GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICALS BY REGION, 2016 (%) 100
COMPETITIVE SUMMARY 101
TABLE 39 GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCT SUPPLIERS, 2016 ($ MILLIONS) 102
FIGURE 22 GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCT SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%) 102
PRODUCT INTRODUCTIONS 103
ALLERGY AND RESPIRATORY DRUGS 103
Companion Animals: Allergy and Inflammatory Diseases 103
Allergies 103
Arthritis 103
Asthma 104
Dermatitis 104
Eosinophilic Granuloma Complex 104
Gout 105
Target Species and Providers 105
Boehringer Ingelheim 105
TABLE 40 BOEHRINGER INGELHEIM'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES 106
Elanco 106
TABLE 41 ELANCO'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES 106
Heska 106
TABLE 42 HESKA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES 106
Huvepharma 107
TABLE 43 HUVEPHARMA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES 107
Virbac 107
TABLE 44 VIRBAC'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES 107
Zoetis 107
TABLE 45 ZOETIS' ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES 108
FIGURE 23 ZOETIS' ALLERGY AND RESPIRATORY DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 108
Allergy and Respiratory Market Analysis 109
FIGURE 24 GLOBAL MARKET FOR ALLERGY AND RESPIRATORY PRODUCTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 109
ANTI-INFECTIVES AND ANTIFUNGALS 110
Companion Animals - Bacterial Infections 111
Black Tongue 111
Bordetella 111
Brucellosis 111
Campylobacteriosis 111
Chlamydia 112
Leptospirosis 112
Lyme Disease 113
Q Fever 113
Respiratory Mycoplasmosis 114
Spirochaetaceae 114
Tetanus 114
Production Animals - Bacterial Infections 114
Anthrax 114
Blackleg 115
Conjunctivitis 115
Tetanus 115
Ehrlichia Ruminantium (previously known as Heartwater) 115
Pneumonia 116
Providers 116
Bayer 116
TABLE 46 BAYER'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES 116
FIGURE 25 BAYER'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 117
Boehringer Ingelheim 118
TABLE 47 BOEHRINGER INGELHEIM'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES 118
ECO 118
TABLE 48 ECO ANIMAL HEALTH'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES 118
Elanco 118
TABLE 49 ELANCO'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES 119
FIGURE 26 ELANCO'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 119
Esteve 120
TABLE 50 ESTEVE'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES 121
Merck Animal Health 121
TABLE 51 MERCK'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES 121
FIGURE 27 MERCK'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 122
Merial - Sanofi 122
TABLE 52 MERIAL'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES 122
Virbac 123
TABLE 53 VIRBAC'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES 123
Zoetis 123
TABLE 54 ZOETIS' ANTI-INFECTIVE DRUGS BY TARGET SPECIES 124
FIGURE 28 ZOETIS' ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 124
Anti-Infectives Market Analysis 125
FIGURE 29 GLOBAL MARKET FOR ANTI-INFECTIVES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 125
ANTI-INFLAMMATORIES AND ANALGESICS 126
Providers 126
Aratana Therapeutics 126
TABLE 55 ARATANA THERAPEUTICS' ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES 127
Bayer 127
TABLE 56 BAYER ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES 127
Boehringer Ingelheim 127
TABLE 57 BOEHRINGER INGELHEIM'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES 128
Elanco 128
TABLE 58 ELANCO'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES 128
FIGURE 30 ELANCO'S ANTI-INFLAMMATORIES AND ANALGESICS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 128
Esteve 129
TABLE 59 ESTEVE'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES 130
Merck Animal Health 130
TABLE 60 MERCK'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES 130
Merial 130
TABLE 61 MERIAL'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES 131
Zoetis 131
TABLE 62 ZOETIS' ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES 131
FIGURE 31 ZOETIS' ANTI-INFLAMMATORIES AND ANALGESICS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 131
Anti-Inflammatory Market Analysis 132
FIGURE 32 GLOBAL MARKET FOR ANTI-INFLAMMATORIES AND ANALGESICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 133
METABOLIC AND ENDOCRINE DISORDER DRUGS 133
Metabolic Diseases and Endocrine Disorders 134
Cushing's Syndrome 134
Diabetes Mellitus 134
Thyroid Disease 135
Pancreatitis 136
Metabolic Bone Disease in Birds 136
Providers 136
Aratana Therapeutics 136
TABLE 63 ARATANA THERAPEUTICS' METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES 137
Bayer 137
TABLE 64 BAYER'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES 137
Boehringer Ingelheim 137
TABLE 65 BOEHRINGER INGELHEIM'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES 137
Merck 138
TABLE 66 MERCK'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES 138
FIGURE 33 MERCK'S METABOLIC AND ENDOCRINE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%) 138
Merial 139
TABLE 67 MERIAL'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES 139
Virbac 140
TABLE 68 VIRBAC'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES 140
Zoetis 140
TABLE 69 ZOETIS' METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES 140
FIGURE 34 ZOETIS' METABOLIC AND ENDOCRINE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 140
Metabolic Drug Market Analysis 141
FIGURE 35 GLOBAL MARKET FOR METABOLIC DRUGS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 142
PARASITICIDES 142
Companion Animals - Parasitic Diseases 142
Ear Mites 142
Fleas 143
Heartworm 144
Hemotropic Mycoplasmas (formerly Hemobartonellosis) 145
Feline Scabies 145
Lice 145
Sarcoptic Mange 146
Worms 146
Production Animals - Parasitic Disease Example 147
Texas Cattle Fever 147
Providers 147
Bayer 147
TABLE 70 BAYER'S PARASITICIDES BY TARGET SPECIES 148
FIGURE 36 BAYER'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 148
Beaphar 149
TABLE 71 BEAPHAR'S PARASITICIDES BY TARGET SPECIES 149
Boehringer Ingelheim 149
TABLE 72 BOEHRINGER INGELHEIM'S PARASITICIDES BY TARGET SPECIES 149
ECO 150
TABLE 73 ECO ANIMAL HEALTH'S PARASITICIDES BY TARGET SPECIES 150
Elanco 150
TABLE 74 ELANCO'S PARASITICIDES BY TARGET SPECIES 152
FIGURE 37 ELANCO'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 152
Huvepharma 153
TABLE 75 PARASITICIDES BY TARGET SPECIES 153
Merck Animal Health 153
TABLE 76 MERCK'S PARASITICIDES BY TARGET SPECIES 154
FIGURE 38 MERCK'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 155
Merial 155
TABLE 77 MERIAL'S PARASITICIDES BY TARGET SPECIES 157
FIGURE 39 MERIAL'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 158
Virbac 158
TABLE 78 VIRBAC'S PARASITICIDES BY TARGET SPECIES 159
Zoetis 159
TABLE 79 ZOETIS' PARASITICIDES BY TARGET SPECIES 159
FIGURE 40 ZOETIS' PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 160
Parasiticide Market Analysis 160
FIGURE 41 GLOBAL MARKET FOR PARASITICIDES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 161
PSYCHOTROPIC MEDICATIONS 162
Providers 162
Elanco 162
TABLE 80 ELANCO'S PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES 162
Vetoquinol 162
TABLE 81 VETOQUINOL'S PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES 162
Zoetis 163
TABLE 82 ZOETIS' PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES 163
Natural Remedies 163
Psychotropic Market Analysis 163
FIGURE 42 GLOBAL MARKET FOR PSYCHOTROPICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 163
OTHER PHARMACEUTICALS 164
Companion Animals - Other Diseases 164
Equine Protozoal Myelitis 164
Leptospirosis and Equine Recurrent Uveitis 165
Urinary Diseases 165
Glomerulonephritis 165
Feline Lower Urinary Tract Disease 165
Neoplastic Disease 166
Heart Disease 168
Inflammatory Bowel Disease 168
Providers 168
Bayer 168
TABLE 83 BAYER'S OTHER PHARMACEUTICALS BY TARGET SPECIES 168
Boehringer Ingelheim 169
TABLE 84 BOEHRINGER INGELHEIM'S OTHER PHARMACEUTICALS BY TARGET SPECIES 169
Elanco 169
TABLE 85 ELANCO'S OTHER PHARMACEUTICALS BY TARGET SPECIES 170
Esteve 170
TABLE 86 ESTEVE'S OTHER PHARMACEUTICALS BY TARGET SPECIES 170
HbO2 Therapeutics LLC 170
TABLE 87 HBO2 THERAPEUTICS' OTHER PHARMACEUTICALS BY TARGET SPECIES 171
Merck Animal Health 171
TABLE 88 MERCK'S OTHER PHARMACEUTICALS BY TARGET SPECIES 171
Merial 171
TABLE 89 MERIAL'S OTHER PHARMACEUTICALS BY TARGET SPECIES 172
Virbac 172
TABLE 90 VIRBAC'S OTHER PHARMACEUTICALS BY TARGET SPECIES 172
Zoetis 172
TABLE 91 ZOETIS' OTHER PHARMACEUTICALS BY TARGET SPECIES 172
FIGURE 43 ZOETIS' OTHER PHARMACEUTICALS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 172
Dental 173
TABLE 92 DENTAL PHARMACEUTICALS BY TARGET SPECIES AND PROVIDER 173
Other Pharmaceuticals Market Analysis 174
FIGURE 44 GLOBAL MARKET FOR OTHER PHARMACEUTICALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 174
CHAPTER 7 ANIMAL FEED ADDITIVES 176
OVERVIEW 176
GLOBAL MARKET ANALYSIS AND CONSIDERATIONS 177
TABLE 93 GLOBAL MARKET FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, THROUGH 2021 ($ MILLIONS) 178
FIGURE 45 GLOBAL MARKET FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, 2014-2021 ($ MILLIONS) 178
COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS 178
TABLE 94 GLOBAL MARKET FOR FEED ADDITIVES BY ANIMAL GROUP, THROUGH 2021 178
FIGURE 46 GLOBAL MARKET SHARES OF FEED ADDITIVES BY ANIMAL GROUP, 2016 (%) 179
MARKETS BY GEOGRAPHICAL REGION 179
TABLE 95 GLOBAL MARKET FOR ANIMAL FEED ADDITIVES BY REGION, THROUGH 2021 ($ MILLIONS) 180
FIGURE 47 GLOBAL MARKET SHARES OF ANIMAL FEED ADDITIVES BY REGION, 2016 (%) 180
COMPETITIVE SUMMARY 181
TABLE 96 GLOBAL MARKET SHARES OF SUPPLIERS OF ANIMAL FEED ADDITIVES, 2016 ($ MILLIONS/%) 182
FIGURE 48 GLOBAL MARKET SHARES OF SUPPLIERS OF ANIMAL FEED ADDITIVES, 2016 (%) 182
PRODUCT INTRODUCTIONS 183
AMINO ACIDS 183
Providers 183
Adisseo - Bluestar 183
TABLE 97 ADISSEO'S AMINO ACIDS BY TARGET SPECIES 183
Ajinomoto 183
TABLE 98 AJINOMOTO'S AMINO ACIDS BY TARGET SPECIES 184
Boehringer Ingelheim 184
TABLE 99 BOEHRINGER INGELHEIM'S AMINO ACIDS BY TARGET SPECIES 184
Evonik 184
TABLE 100 EVONIK'S AMINO ACIDS BY TARGET SPECIES 185
Novus International 185
TABLE 101 NOVUS INTERNATIONAL'S AMINO ACIDS BY TARGET SPECIES 185
Amino Acid Market Analysis 186
FIGURE 49 GLOBAL MARKET FOR AMINO ACIDS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 186
MEDICINAL ADDITIVES 186
Providers 187
ECO 187
TABLE 102 MEDICINAL ADDITIVES BY TARGET SPECIES 187
Elanco 187
TABLE 103 ELANCO'S MEDICINAL ADDITIVES BY TARGET SPECIES 188
FIGURE 50 ELANCO'S MEDICINAL ADDITIVES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 188
Huvepharma 189
Merck 189
TABLE 104 MERCK'S MEDICINAL ADDITIVES BY TARGET SPECIES 190
Merial 190
TABLE 105 MERIAL'S MEDICINAL ADDITIVES BY TARGET SPECIES 190
Phibro Animal Health 190
TABLE 106 PHIBRO'S MEDICINAL ADDITIVES BY TARGET SPECIES 190
Zoetis 191
TABLE 107 ZOETIS' MEDICINAL ADDITIVES BY TARGET SPECIES 191
FIGURE 51 ZOETIS' MEDICINAL ADDITIVES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 192
Medicinal Feed Additive Market Analysis 192
FIGURE 52 GLOBAL MARKET FOR MEDICINAL FEED ADDITIVES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 193
NUTRITIONAL SUPPLEMENTS 194
Providers 194
Adisseo - Bluestar 194
TABLE 108 ADISSEO (BLUESTAR) NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 194
Bayer 194
TABLE 109 BAYER'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 194
BASF 194
TABLE 110 BASF'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 194
Beaphar 195
TABLE 111 BEAPHAR'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 195
Boehringer Ingelheim 195
TABLE 112 BOEHRINGER INGELHEIM'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 195
FIGURE 53 BOEHRINGER INGELHEIM'S NUTRITIONAL SUPPLEMENTS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%) 196
DSM Nutritional Products 197
TABLE 113 DSM'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 197
Elanco 197
TABLE 114 ELANCO'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 197
FIGURE 54 ELANCO'S NUTRITIONAL SUPPLEMENTS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 197
Esteve 198
TABLE 115 ESTEVE'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 198
Heska 199
TABLE 116 HESKA'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 199
Mosaic 199
TABLE 117 MOSAIC'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 199
Virbac 199
TABLE 118 NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES 200
Nutritional Supplement Market Analysis 200
FIGURE 55 GLOBAL MARKET FOR NUTRITIONAL SUPPLEMENTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 200
VITAMINS AND MINERALS 201
Providers 201
Adisseo - Bluestar 201
TABLE 119 ADISSEO'S VITAMINS AND MINERALS BY TARGET SPECIES 202
BASF 202
TABLE 120 BASF'S VITAMINS AND MINERALS BY TARGET SPECIES 202
Beaphar 202
TABLE 121 BEAPHAR'S VITAMINS AND MINERALS BY TARGET SPECIES 203
DSM Nutritional Products 203
TABLE 122 DSM'S VITAMINS AND MINERALS BY TARGET SPECIES 203
Merck Animal Health 203
TABLE 123 MERCK'S VITAMINS AND MINERALS BY TARGET SPECIES 204
Zoetis 204
TABLE 124 ZOETIS' VITAMINS AND MINERALS BY TARGET SPECIES 204
FIGURE 56 ZOETIS' VITAMINS AND MINERALS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 204
Vitamin and Mineral Market Analysis 205
FIGURE 57 GLOBAL MARKET FOR VITAMINS AND MINERALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 206
CHAPTER 8 ANIMAL DIAGNOSTICS 208
OVERVIEW 208
GLOBAL MARKET ANALYSIS AND CONCLUSION 208
TABLE 125 GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY TYPE, THROUGH 2021 ($ MILLIONS) 209
FIGURE 58 GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY TYPE, 2014-2021 ($ MILLIONS) 209
COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS 209
TABLE 126 GLOBAL MARKET FOR ANIMAL DIAGNOSTIC PRODUCTS BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS) 210
FIGURE 59 GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS BY ANIMAL GROUP, 2016 (%) 210
MARKETS BY GEOGRAPHICAL REGION 211
TABLE 127 GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY REGION, THROUGH 2021 ($ MILLIONS) 211
FIGURE 60 GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS BY REGION, 2016 (%) 211
FIGURE 61 GLOBAL MARKET SHARE OF ANIMAL DIAGNOSTICS BY COUNTRY, 2016 (%) 213
COMPETITIVE SUMMARY 213
TABLE 128 GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 ($ MILLIONS/%) 214
FIGURE 62 GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTIC SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%) 214
PRODUCT PROVIDERS AND DESCRIPTIONS 215
ABAXIS 215
TABLE 129 ABAXIS' DIAGNOSTICS BY TARGET SPECIES 215
BEAPHAR 215
TABLE 130 BEAPHAR'S DIAGNOSTICS BY TARGET SPECIES 216
HESKA 216
TABLE 131 HESKA'S DIAGNOSTICS BY TARGET SPECIES 216
FIGURE 63 HESKA'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%) 216
IDEXX 217
TABLE 132 IDEXX'S DIAGNOSTICS BY TARGET SPECIES 218
FIGURE 64 IDEXX'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%) 219
MERCK ANIMAL HEALTH 220
TABLE 133 MERCK'S DIAGNOSTICS BY TARGET SPECIES 221
VIRBAC 221
TABLE 134 VIRBAC'S DIAGNOSTICS BY TARGET SPECIES 221
FIGURE 65 VIRBAC'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 221
ZOETIS 222
TABLE 135 ZOETIS' DIAGNOSTICS BY TARGET SPECIES 222
FIGURE 66 ZOETIS' DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%) 223
FIGURE 67 ZOETIS' FELINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%) 223
FIGURE 68 ZOETIS' CANINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%) 224
FIGURE 69 ZOETIS' EQUINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%) 225
FIGURE 70 ZOETIS' RUMINANT DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%) 227
FIGURE 71 ZOETIS' SWINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%) 227
FIGURE 72 ZOETIS' AVIAN DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%) 229
PRODUCT SEGMENTS 230
DIAGNOSTIC RAPID TESTING MARKET ANALYSIS 230
FIGURE 73 GLOBAL MARKET FOR RAPID DIAGNOSTIC TESTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 230
FIGURE 74 GLOBAL MARKET FOR RAPID DIAGNOSTICS BY TEST TYPE (VETERINARY APPLICATIONS), 2014-2021 ($ MILLIONS) 231
MARKET ANALYSIS OF DIAGNOSTIC ANALYZERS AND CONSUMABLES 232
FIGURE 75 GLOBAL MARKET FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 232
FIGURE 76 GLOBAL MARKET FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY TEST TYPE (VETERINARY APPLICATIONS), 2014-2021 ($ MILLIONS) 233
MARKET ANALYSIS OF DIAGNOSTIC IMAGING EQUIPMENT 233
FIGURE 77 GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT AND RELATED MATERIALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 233
CHAPTER 9 MARKET SUMMARY 236
GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET ANALYSIS 236
TABLE 136 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, THROUGH 2021 ($ MILLIONS) 236
FIGURE 78 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, 2014-2021 ($ MILLIONS) 236
MARKETS BY USE OR ANIMAL GROUP 237
TABLE 137 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP THROUGH 2021 ($ MILLIONS) 238
FIGURE 79 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS) 238
FIGURE 80 GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP, 2016 (%) 238
MARKETS BY WORLD REGION 239
TABLE 138 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, THROUGH 2021 ($ MILLIONS) 240
FIGURE 81 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, 2014-2021 ($ MILLIONS) 240
FIGURE 82 GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, 2016 (%) 240
FIGURE 83 GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY SELECT COUNTRY, 2016 (%) 242
COMPETITIVE ANALYSIS 242
TABLE 139 GLOBAL MARKET SHARES AND REVENUE OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER, 2016 ($ MILLIONS/%) 243
FIGURE 84 GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER REVENUES, 2016 (%) 243
TABLE 140 MAJOR INDUSTRY PARTICIPATION BY ANIMAL HEALTH SUPPLIERS 244
CHAPTER 10 PATENT ANALYSIS 246
OVERVIEW 246
INNOVATION IN DRUG DELIVERY 246
TRANSDERMAL (SPRAY-ON) DRUGS 246
SUBLINGUAL (UNDER THE TONGUE) DRUGS 247
EFFERVESCENT TABLET VACCINE DELIVERY 247
STERILIZATION METHODS 247
PATENT PRODUCT SEGMENTS 248
PATENTS FILED BY YEAR 248
TABLE 141 ANNUAL DISTRIBUTION OF U.S. PATENTS GRANTED ON ANIMAL HEALTH PRODUCTS, JAN. 1, 2000-OCT. 1, 2016 (NUMBER) 248
FIGURE 85 ANNUAL DISTRIBUTION OF U.S. PATENTS GRANTED ON ANIMAL HEALTH PRODUCTS, JAN. 1, 2000-OCT. 1, 2016 (NO. OF PATENTS) 248
INTERNATIONAL PATENTS BY COUNTRY 249
TABLE 42 HESKA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES 249
PATENTS ISSUED BY PATENT HOLDER 250
TABLE 143 DISTRIBUTION OF U.S. PATENTS ON ANIMAL HEALTH PRODUCTS BY PATENT HOLDER, JAN. 1, 1976-OCT. 1, 2016 (NUMBER OF PATENTS) 250
CHAPTER 11 COMPANY PROFILES 253
OVERVIEW 253
TABLE 144 COMPETITOR MARKET POSITION IN ANIMAL THERAPEUTICS AND DIAGNOSTICS BY SEGMENT, 2016 ($ MILLIONS) 253
PROFILES 254
ABAXIS INC. 254
AJINOMOTO CO. INC. 255
ARATANA THERAPEUTICS INC. 255
BASF ANIMAL NUTRITION 256
BAYER ANIMAL HEALTH GMBH 257
BLUESTAR GROUP-CHINA NATIONAL BLUESTAR CO. LTD. 258
BOEHRINGER INGELHEIM VETMEDICA INC. 258
DSM NUTRITIONAL PRODUCTS LTD. 259
ELANCO ANIMAL HEALTH 260
EVONIK INDUSTRIES AG 261
HESKA CORP. 261
IDEXX LABORATORIES INC. 262
MERCK ANIMAL HEALTH 263
MERIAL SAS 264
MOSAIC CO. (THE) 265
VIRBAC S.A. 265
ZOETIS INC. 266

LIST OF TABLES
SUMMARY TABLE GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, THROUGH 2021 ($ MILLIONS) 7
TABLE 1 GESTATION PERIODS OF SELECT COMMON SPECIES 12
TABLE 2 LIFESPAN OF COMMON AVIAN SPECIES OF PETS 15
TABLE 3 STATISTICS FOR COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2011, 2014 AND 2016 (THOUSANDS/%) 15
TABLE 4 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2014 AND 2016 (THOUSANDS) 16
TABLE 5 REPORTED POPULATION OF FOOD PRODUCTION ANIMALS IN THE UNITED STATES, 2005, 2010, 2014, 2016 AND PROJECTED 2017 (THOUSANDS) 17
TABLE 6 TOP BROILER PRODUCING STATES, 2015 (THOUSANDS) 18
TABLE 7 TOP RED MEAT PRODUCING STATES, 1990 AND 2015 (%) 18
TABLE 8 DOG (CANINE) POPULATION BY SELECT COUNTRY, 2015 (THOUSANDS) 19
TABLE 9 CAT (FELINE) POPULATION BY SELECT COUNTRY, 2015 (THOUSANDS) 20
TABLE 10 HORSE (EQUINE) POPULATION BY COUNTRY, 2016 (THOUSANDS) 20
TABLE 11 CATTLE (BOVINE) POPULATION BY COUNTRY, 2016 (THOUSANDS) 21
TABLE 12 PIG/HOG (SWINE) POPULATION BY COUNTRY, 2016 (THOUSANDS) 21
TABLE 13 COMMON EXAMPLES OF ZOONOTIC DISEASES 24
TABLE 14 AFFECTED PIONEER ANTIMICROBIALS USED IN FOOD-PRODUCING ANIMALS IN THE UNITED STATES 29
TABLE 15 ANTIMICROBIAL DRUG USE AND SALES IN FOOD-PRODUCING ANIMALS, 2010, 2011 AND 2014 (KG*) 35
TABLE 16 APPA NATIONAL PET OWNERS SURVEY, 2013 AND 2014 BASIC ANNUAL EXPENSES FOR DOGS AND CATS (U.S. SPENDING, $) 44
TABLE 17 PET INSURANCE PLAN COMPARISONS, UNITED STATES 44
TABLE 18 NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS. 2015 48
TABLE 19 ESTIMATED NUMBER OF U.S. PRIVATE VETERINARIAN PRACTICES, BY TYPE OF PRACTICE, 2013 AND 2015 49
TABLE 20 GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS) 50
TABLE 21 GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS) 53
TABLE 22 GLOBAL MARKET FOR ANIMAL VACCINES BY REGION, THROUGH 2021 ($ MILLIONS) 55
TABLE 23 GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 ($ MILLIONS/%) 56
TABLE 24 HENDRA VIRUS EQUINE INCIDENTS (NUMBER OF REPORTED CASES) 63
TABLE 25 BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES BY TARGET SPECIES 69
TABLE 26 ELANCO'S COMPANION ANIMAL VACCINES BY TARGET SPECIES 70
TABLE 27 MERCK'S COMPANION ANIMAL VACCINES BY TARGET SPECIES 71
TABLE 28 MERIAL'S COMPANION ANIMAL VACCINES BY TARGET SPECIES 73
TABLE 29 ZOETIS' COMPANION ANIMAL VACCINES BY TARGET SPECIES 75
TABLE 30 BAYER'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 83
TABLE 31 BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 84
TABLE 32 ELANCO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 85
TABLE 33 MERCK and CO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 87
TABLE 34 MERIAL'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES 89

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Animal Feed Additives Market, Mordor Intelligence LLP

Global Animal Feed Additives Market, Mordor Intelligence LLP

  • $ 9500
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The Global Animal Feed Additives market is projected to cross USD 37 billion by 2021 from USD 28.6 billion in 2016, growing at a CAGR of 5.34% over the forecast period. Feed additives are essential in ...

Sleep Aids: Technologies and Global Markets

Sleep Aids: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Analyze the current market dynamics and evaluate the effect of strategic factors such as technology-driven change and industry consolidation of sleep aids and technologies. - Review ...

BRIC Vision Care Market Outlook to 2022

BRIC Vision Care Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

BRIC Vision Care Market Outlook to 2022 Summary GlobalData’s new report, "BRIC Vision Care Market Outlook to 2022", provides key market data on the BRIC Vision Care market. The report provides value, ...


Download Unlimited Documents from Trusted Public Sources

HIV AIDS Statistics in South Africa

  • February 2017
    8 pages
  • HIV AIDS  

    Food  

  • South Africa  

View report >

OTC Industry in Japan

  • February 2017
    8 pages
  • Vitamin  

  • Japan  

View report >

The future of the Pain Relief Industry in the UK

  • February 2017
    5 pages
  • Pain Relief  

  • United Kingdom  

View report >

Otc Industry In Spain

10 days ago

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.